- Volume 17 Issue 2
DOI QR Code
Evaluation of a Colorectal Carcinoma Screening Program in Kota Setar and Kuala Muda Districts, Malaysia
- Abu Hassan, Muhammad Radzi (Clinical Research Centre, Sultanah Bahiyah Hospital) ;
- Leong, Tan Wei (Clinical Research Centre, Sultanah Bahiyah Hospital) ;
- Andu, Delarina Frimawati Othman (Clinical Research Centre, Sultanah Bahiyah Hospital) ;
- Hat, Habshoh (Bandar Sungai Petani Health Clinic) ;
- Mustapha, Nik Raihan Nik (Pathology Department, Sultanah Bahiyah Hospital)
- Published : 2016.03.07
Background: A colorectal cancer screening program was piloted in two districts of Kedah in 2013. There is scarcity of information on colorectal cancer screening in Malaysia. Objective: Thus, this research was conducted to evaluate the colorectal cancer screening program in the districts to provide insights intop its efficacy. Materials and Methods: A cross sectional study was conducted using data on the colorectal cancer screening program in 2013 involving Kota Setar and Kuala Muda districts in Malaysia. We determined the response rate of immunochemical fecal occult blood test (iFOBT), colonoscopy compliance, and detection rates of neoplasia and carcinoma. We also compared the response of FOBT by demographic background. Results: The response rate of FOBT for first iFOBT screening was 94.7% while the second iFOBT screening was 90.7%. Participants from Kuala Muda district were 27 times more likely to default while Indians had a 3 times higher risk of default compared to Malays. The colonoscopy compliance was suboptimal among those with positive iFOBT. The most common finding from colonoscopy was hemorrhoids, followed by tubular adenoma. Detection rate of carcinoma and neoplasia for our program was 1.2%. Conclusions: In summary, the response rate of iFOBT was encouraging but the colonoscopy compliance was suboptimal which led to a considerably low detection rate.
- Cairns SR, Scholefield J (2002). Guidelines for colorectal cancer screening in high risk groups. Gut, 51, 1-2. https://doi.org/10.1136/gut.51.1.e1
- Cairns SR, Scholefield JH, Steele RJ, et al (2010). Guidelines for colorectal cancer screening and surveillance in moderate and high risk groups. Gut, 59, 666-89.
- Castiglione G, Zappa M, Grazzini G, et al (1996). Immunochemical vs guaiac faecal occult blood tests in a population-based screening programme for colorectal cancer. British J Cancer, 74, 141. https://doi.org/10.1038/bjc.1996.329
- Compton CC, Fielding LP, Burgart LJ, et al (2000). Prognostic factors in colorectal cancer. Arch Pathol Lab Med, 124, 979-94.
- Ferrat E, Le Breton J, Veerabudun K, et al (2013). Colorectal cancer screening: factors associated with colonoscopy after a positive faecal occult blood test. Br J Cancer, 109, 1437-44. https://doi.org/10.1038/bjc.2013.476
- Frazier AL, Colditz GA, Fuchs CS, et al (2000). Costeffectiveness of screening for colorectal cancer in the general population. JAMA, 284, 1954-61. https://doi.org/10.1001/jama.284.15.1954
- Hardcastle JD, Chamberlain JO, Robinson MH, et al (1996). Randomised controlled trial of faecal-occult-blood screening for colorectal cancer. Lancet, 348, 1472-7. https://doi.org/10.1016/S0140-6736(96)03386-7
- Hewitson P, Glasziou P, Watson E, et al (2008). Cochrane systematic review of colorectal cancer screening using the fecal occult blood test (hemoccult): an update. Am J Gastroenterol 103, 1541-9. https://doi.org/10.1111/j.1572-0241.2008.01875.x
- Kronborg O, Fenger C, Olsen J, et al (1996). Randomised study of screening for colorectal cancer with faecal-occult-blood test. Lancet, 348, 1467-71. https://doi.org/10.1016/S0140-6736(96)03430-7
- Launoy GD, Bertrand HJ, Berchi C, et al (2005). Evaluation of an immunochemical fecal occult blood test with automated reading in screening for colorectal cancer in a general average-risk population. Int J Cancer, 115, 493-6. https://doi.org/10.1002/ijc.20921
- Leuraud K, Jezewski-Serra D, Viguier J, et al (2013). Colorectal cancer screening by guaiac faecal occult blood test in France:Evaluation of the programme two years after launching. Cancer Epidemiol, 37, 959-67. https://doi.org/10.1016/j.canep.2013.07.008
- Logan RF, Patnick J, Nickerson C, et al (2012). Outcomes of the bowel cancer screening programme (BCSP) in England after the first 1 million tests. Gut, 61, 1439-46. https://doi.org/10.1136/gutjnl-2011-300843
- Meester RG, Doubeni CA, Lansdorp-Vogelaar I, et al (2015). Colorectal cancer deaths attributable to nonuse of screening in the United States. Ann Epidemiol, 25, 208-13. https://doi.org/10.1016/j.annepidem.2014.11.011
- Ministry of Health, Malaysia (2007). National cancer registry report: malaysia cancer statistics - data and Figure.
- Moss S, Campbell C, Melia J, et al (2011). Performance measures in three rounds of the English bowel cancer screening pilot. Gut, 2010, 236430.
- O'Connell JB, Maggard MA, Ko CY (2004). Colon cancer survival rates with the new american joint committee on cancer sixth edition staging. J Natl Cancer Inst, 96, 1420-5. https://doi.org/10.1093/jnci/djh275
- Oono Y, Iriguchi Y, Doi Y, et al (2010). A retrospective study of immunochemical fecal occult blood testing for colorectal cancer detection. Clinica Chimica Acta, 411, 802-5.
- Steele R, Kostourou I, McClements P, et al (2010). Effect of gender, age and deprivation on key performance indicators in a FOBT-based colorectal screening programme. J Med Screen, 17, 68-74.
- Winawer S, Fletcher R, Rex D, et al (2003). Colorectal cancer screening and surveillance: clinical guidelines and rationaleupdate based on new evidence. Gastroenterol, 124, 544-60. https://doi.org/10.1053/gast.2003.50044
- The compliance rate for the second diagnostic evaluation after a positive fecal occult blood test: A systematic review and meta-analysis pp.2050-6414, 2019, https://doi.org/10.1177/2050640619828185